Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Titel:
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Auteur:
Tsai, Chiaojung Jillian Yang, Jonathan T Shaverdian, Narek Patel, Juber Shepherd, Annemarie F Eng, Juliana Guttmann, David Yeh, Randy Gelblum, Daphna Y Namakydoust, Azadeh Preeshagul, Isabel Modi, Shanu Seidman, Andrew Traina, Tiffany Drullinsky, Pamela Flynn, Jessica Zhang, Zhigang Rimner, Andreas Gillespie, Erin F Gomez, Daniel R Lee, Nancy Y Berger, Michael Robson, Mark E Reis-Filho, Jorge S Riaz, Nadeem Rudin, Charles M Powell, Simon N